My bookmarksSign up free
Source

2011/869/EU: Commission Decision of 20 December 2011 amending Decision 2002/364/EC on common technical specifications for in vitro diagnostic medical devices (notified under document C(2011) 9398) Text with EEA relevance

2011/869/EU: Commission Decision of 20 December 2011 amending Decision 2002/364/EC on common technical specifications for in vitro diagnostic medical devices (notified under document C(2011) 9398) Text with EEA relevance

Decision 2002/364/EC · Decision · 4 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The Annex to Decision 2002/364/EC is amended in accordance with the Annex to this Decision.

Article 2

Open ↗

This Decision shall apply from 1st of July 2012. However, Member States shall allow manufacturers to apply the requirements set out in the Annex before the date set out in the first paragraph of this Article.

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX 1.    The following section is added at the end of Section 3 of the Annex to Decision 2002/364/EC: ‘3.7.    CTS for Variant Creutzfeldt-Jakob disease (vCJD) assays for blood screening CTS for Variant Creutzfeldt-Jakob disease (vCJD) assays for blood screening are set out in Table 11’ 2.    The following table is added at the end of the Annex to Decision 2002/364/EC: ‘ Table 11 Variant Creutzfeldt-Jakob disease (vCJD) assays for blood screening   Material Number of specimens Acceptance Criteria Analytical sensitivity vCJD brain spikes in human plasma (WHO reference number NHBY0/0003) 24 replicates of each of three dilutions of the material WHO number NHBY0/0003 (1×10 4 , 1×10 5 , 1×10 6 ) 23 of the 24 replicates detected at 1×10 4 vCJD spleen spikes in human plasma (10 % spleen homogenate — NIBSC reference number NHSY0/0009) 24 replicates of each of three dilutions of the material NIBSC number NHSY0/0009 (1×10, 1×10 2 , 1×10 3 ) 23 of the 24 replicates detected at 1×10 Diagnostic sensitivity A) Specimen from appropriate animal models As many specimen as reasonably possible and available, and at least 10 specimens 90  % B) Specimen from humans with known clinical vCJD As many specimen as reasonably possible and available, and at least 10 specimens 90  % Only in case where 10 specimens are not available: — the number of specimens tested shall be comprised between 6 and 9 — all available specimens shall be tested no more than one false negative result Analytical specificity Potentially cross-reacting blood-specimens 100   Diagnostic specificity Normal human plasma samples from area of low BSE exposure 5 000 At least 99,5 %’

Other acts of the same type
2012/107/EU: Council Decision of 14 December 2011 on the signing, on behalf of the Union, and provisional application of the Agreement in the form of an Exchange of Letters between the European Union and the Government of the Russian Federation relating to the preservation of commitments on trade in services contained in the current EU-Russia Partnership and Cooperation Agreement2012/108/EU: Council Decision of 14 December 2011 on the signing, on behalf of the Union, and provisional application of the Agreement in the form of an Exchange of Letters between the European Union and the Russian Federation relating to the introduction or increase of export duties on raw materials2011/834/EU: Commission Decision of 13 December 2011 terminating the anti-subsidy proceeding concerning imports of certain polyethylene terephthalate originating in Oman and Saudi Arabia2011/835/EU: Commission Decision of 13 December 2011 terminating the anti-dumping proceeding concerning imports of certain polyethylene terephthalate originating in Oman and Saudi Arabia2011/842/EU: Council Decision of 13 December 2011 on the full application of the provisions of the Schengen acquis in the Principality of Liechtenstein2011/843/EU: Commission Implementing Decision of 13 December 2011 on the Union financial contribution to national programme of the Kingdom of Spain in 2011 for the collection, management and use of data in the fisheries sector (notified under document C(2011) 9318)2012/3/EU: Decision of the European Parliament and of the Council of 13 December 2011 on the mobilisation of the Flexibility Instrument2012/4/EU: Decision of the European Parliament and of the Council of 13 December 2011 on the mobilisation of the European Globalisation Adjustment Fund in accordance with point 28 of the Interinstitutional Agreement of 17 May 2006 between the European Parliament, the Council and the Commission on budgetary discipline and sound financial management (application EGF/2011/005 PT/Norte-Centro Automotive from Portugal)2012/6/EU: Decision of the European Parliament and of the Council of 13 December 2011 on mobilisation of the European Union Solidarity Fund, in accordance with point 26 of the Interinstitutional Agreement of 17 May 2006 between the European Parliament, the Council and the Commission on budgetary discipline and sound financial management2012/7/EU: Decision of the European Parliament and of the Council of 13 December 2011 on the mobilisation of the European Globalisation Adjustment Fund in accordance with point 28 of the Interinstitutional Agreement of 17 May 2006 between the European Parliament, the Council and the Commission on budgetary discipline and sound financial management (application EGF/2011/002 IT/Trentino-Alto Adige/Südtirol Construction of buildings from Italy)Decision No U4 of 13 December 2011 concerning the reimbursement procedures under Article 65(6) and (7) of Regulation (EC) No 883/2004 and Article 70 of Regulation (EC) No 987/2009 Text of relevance to the EEA and to the EC/Switzerland Agreement2012/381/EU: Council Decision of 13 December 2011 on the conclusion of the Agreement between the European Union and Australia on the processing and transfer of Passenger Name Record (PNR) data by air carriers to the Australian Customs and Border Protection Service

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next